<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Times New Roman",serif;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:18.0pt;
font-family:"Times New Roman",serif;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Calibri Light",sans-serif;
color:#1F4D78;
mso-fareast-language:EN-US;
font-weight:normal;}
h5
{mso-style-priority:9;
mso-style-link:"Heading 5 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:11.0pt;
font-family:"Calibri Light",sans-serif;
color:#2E74B5;
mso-fareast-language:EN-US;
font-weight:normal;}
h6
{mso-style-priority:9;
mso-style-link:"Heading 6 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:11.0pt;
font-family:"Calibri Light",sans-serif;
color:#1F4D78;
mso-fareast-language:EN-US;
font-weight:normal;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-priority:99;
mso-style-link:"Body Text Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;
mso-fareast-language:EN-US;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
{mso-style-priority:11;
mso-style-link:"Subtitle Char";
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
color:#5A5A5A;
letter-spacing:.75pt;
mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
address
{mso-style-priority:99;
mso-style-link:"HTML Address Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman",serif;
font-style:italic;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:36.0pt;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
span.HTMLAddressChar
{mso-style-name:"HTML Address Char";
mso-style-priority:99;
mso-style-link:"HTML Address";
font-family:"Times New Roman",serif;
mso-fareast-language:EN-ZW;
font-style:italic;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Times New Roman",serif;
mso-fareast-language:EN-ZW;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Times New Roman",serif;
mso-fareast-language:EN-ZW;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Calibri Light",sans-serif;
color:#1F4D78;}
span.Heading5Char
{mso-style-name:"Heading 5 Char";
mso-style-priority:9;
mso-style-link:"Heading 5";
font-family:"Calibri Light",sans-serif;
color:#2E74B5;
mso-fareast-language:EN-US;}
span.Heading6Char
{mso-style-name:"Heading 6 Char";
mso-style-priority:9;
mso-style-link:"Heading 6";
font-family:"Calibri Light",sans-serif;
color:#1F4D78;
mso-fareast-language:EN-US;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-priority:99;
mso-style-link:"Body Text";
font-family:"Times New Roman",serif;}
span.SubtitleChar
{mso-style-name:"Subtitle Char";
mso-style-priority:11;
mso-style-link:Subtitle;
font-family:"Calibri",sans-serif;
color:#5A5A5A;
letter-spacing:.75pt;}
p.pb15, li.pb15, div.pb15
{mso-style-name:pb15;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.editor, li.editor, div.editor
{mso-style-name:editor;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.lastupdate, li.lastupdate, div.lastupdate
{mso-style-name:lastupdate;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.insinstorydvcaption, li.insinstorydvcaption, div.insinstorydvcaption
{mso-style-name:ins_instory_dv_caption;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.gray-dark, li.gray-dark, div.gray-dark
{mso-style-name:gray-dark;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.font--body, li.font--body, div.font--body
{mso-style-name:font--body;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.metadatabyline, li.metadatabyline, div.metadatabyline
{mso-style-name:metadata__byline;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.update-time, li.update-time, div.update-time
{mso-style-name:update-time;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.zn-bodyparagraph, li.zn-bodyparagraph, div.zn-bodyparagraph
{mso-style-name:zn-body__paragraph;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.c-readmore, li.c-readmore, div.c-readmore
{mso-style-name:c-readmore;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.text-center, li.text-center, div.text-center
{mso-style-name:text-center;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.image-caption, li.image-caption, div.image-caption
{mso-style-name:image-caption;
mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.chartsubtitle, li.chartsubtitle, div.chartsubtitle
{mso-style-name:chart__subtitle;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
p.chartsource, li.chartsource, div.chartsource
{mso-style-name:chart__source;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle45
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:windowtext;}
span.style30
{mso-style-name:style30;}
span.updated-wrap
{mso-style-name:updated-wrap;}
span.updated-text
{mso-style-name:updated-text;}
span.vjs-control-text
{mso-style-name:vjs-control-text;}
span.vjs-current-time-display
{mso-style-name:vjs-current-time-display;}
span.vjs-duration-display
{mso-style-name:vjs-duration-display;}
span.link600907a1
{mso-style-name:link__600907a1;}
span.pricechangea4e5ebde
{mso-style-name:pricechange__a4e5ebde;}
span.percentchange4644dd7b
{mso-style-name:percentchange__4644dd7b;}
span.nenh5bclitmmlhqori6r
{mso-style-name:nenh5bclitmmlhq_ori6r;}
span.z-TopofFormChar
{mso-style-name:"z-Top of Form Char";
mso-style-priority:99;
mso-style-link:"z-Top of Form";
font-family:"Arial",sans-serif;
display:none;}
span.3vdg7tz3nbnbjk7gdr2y2
{mso-style-name:_3vdg7tz3nbnbjk7gdr2y2_;}
span.2ml6cep2ydeajtymouc70a
{mso-style-name:_2ml6cep2ydeajtymouc70a;}
span.z-BottomofFormChar
{mso-style-name:"z-Bottom of Form Char";
mso-style-priority:99;
mso-style-link:"z-Bottom of Form";
font-family:"Arial",sans-serif;
display:none;}
span.EmailStyle62
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle63
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle64
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.black
{mso-style-name:black;}
span.fs11
{mso-style-name:fs11;}
span.bigfont
{mso-style-name:bigfont;}
span.EmailStyle68
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.pst-byli
{mso-style-name:pst-by_li;}
span.pst-bylnk
{mso-style-name:pst-by_lnk;}
span.trcrboxheaderspan
{mso-style-name:trc_rbox_header_span;}
span.video-label
{mso-style-name:video-label;}
span.trcinlinedetailspacer
{mso-style-name:trc_inline_detail_spacer;}
span.branding
{mso-style-name:branding;}
span.css-128nlh6
{mso-style-name:css-128nlh6;}
span.txtcntnr
{mso-style-name:txtcntnr;}
span.addtxt
{mso-style-name:add__txt;}
span.cmtbtn
{mso-style-name:cmt_btn;}
span.author-name
{mso-style-name:author-name;}
span.font--meta-text
{mso-style-name:font--meta-text;}
span.font-xxxs
{mso-style-name:font-xxxs;}
span.gray
{mso-style-name:gray;}
span.font-bold
{mso-style-name:font-bold;}
span.EmailStyle84
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.metadatabylineauthor
{mso-style-name:metadata__byline__author;}
span.cdheadline-text
{mso-style-name:cd__headline-text;}
span.elstoryelementheader
{mso-style-name:el__storyelement__header;}
span.c-bylineby
{mso-style-name:c-byline__by;}
span.c-bylinename
{mso-style-name:c-byline__name;}
span.c-bylinesource
{mso-style-name:c-byline__source;}
span.c-videodata
{mso-style-name:c-video__data;}
span.c-videotitle
{mso-style-name:c-video__title;}
span.c-captiondesc
{mso-style-name:c-caption__desc;}
span.sr-only
{mso-style-name:sr-only;}
span.c-fontsizersymbol
{mso-style-name:c-fontsizer__symbol;}
span.EmailStyle96
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle97
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.caas-attr-meta-separator
{mso-style-name:caas-attr-meta-separator;}
span.EmailStyle99
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.updated-date
{mso-style-name:updated-date;}
span.custom-caption
{mso-style-name:custom-caption;}
span.ie-custom-caption
{mso-style-name:ie-custom-caption;}
span.EmailStyle103
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle104
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle105
{mso-style-type:personal;
font-family:"Calibri",sans-serif;
color:#1F497D;}
span.EmailStyle107
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1206988569;
mso-list-template-ids:335055086;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-ZW link="#0563C1" vlink="#954F72"><div class=WordSection1><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=919 style='width:689.55pt;border-collapse:collapse'><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border:solid white 1.0pt;border-bottom:none;padding:0cm 5.4pt 0cm 5.4pt'></td><td width=6 style='width:4.4pt;border:none;border-top:solid white 1.0pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='text-indent:33.35pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><a href="https://bullszimbabwe.com/"><span lang=EN-ZW style='color:windowtext;mso-fareast-language:EN-ZW;text-decoration:none'><img border=0 width=246 height=120 id="Picture_x0020_9" src="cid:image001.png@01D6FBBC.CB8E91B0"></span></a><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><a href="http://www.bullszimbabwe.com"><span style='text-decoration:none'>Bullszimbabwe.com </span></a> <a href="mailto:info@bulls.co.zw?subject=View%20and%20Comments"><span style='text-decoration:none'>Views & Comments</span></a> <a href="https://bullszimbabwe.com/category/blogs/bullish-thoughts/"><span style='text-decoration:none'>Bullish Thoughts</span></a> <a href="http://www.twitter.com/BullsBears2010"><span style='text-decoration:none'>Twitter</span></a> <a href="https://www.facebook.com/BullsBearsZimbabwe"><span style='text-decoration:none'>Facebook</span></a> <a href="http://www.linkedin.com/pub/bulls-n-bears-zimbabwe/57/577/72"><span style='text-decoration:none'>LinkedIn</span></a> <a href="https://chat.whatsapp.com/CF6wllAfScU9Wr6dXxoQnO"><span style='text-decoration:none'>WhatsApp</span></a> <a href="mailto:info@bulls.co.zw?subject=Unsubscribe"><span style='text-decoration:none'>Unsubscribe</span></a></span><o:p></o:p></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoSubtitle style='margin-left:32.1pt;text-indent:7.5pt;line-height:105%'><span class=style30><b><span style='font-family:"Verdana",sans-serif;color:windowtext'><o:p> </o:p></span></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><span style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span class=style30><b><span lang=EN-US style='font-family:"Verdana",sans-serif;color:#1F497D'>Coronavirus Global Updates, Feb 19 :::: Brazil Hits 10 Million Covid Cases , Florida Nears 30,000 Deaths and Illinois Cases of U.K. Strain Almost Double</span></b></span><b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span class=style30><b><span style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><span style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td></tr><tr style='height:3.0pt'><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:3.0pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><a href="https://www.nicozdiamond.co.zw/"><span style='font-family:"Calibri",sans-serif;color:windowtext;mso-fareast-language:EN-ZW;text-decoration:none'> </span><span lang=EN-ZW style='font-family:"Calibri",sans-serif;color:windowtext;mso-fareast-language:EN-ZW;text-decoration:none'><img border=0 width=766 height=254 id="Picture_x0020_4" src="cid:image003.jpg@01D706AD.04176570"></span><span lang=EN-ZW style='color:windowtext;text-decoration:none'> </span></a></span><span class=style30><b><span style='font-family:"Verdana",sans-serif'><o:p></o:p></span></b></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.0pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> </span><span style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td></tr><tr style='height:10.05pt'><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:10.05pt'><td width=914 colspan=4 rowspan=3 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><h1 style='line-height:33.75pt;background:white'><span lang=EN-US style='font-size:11.0pt;font-family:"Verdana",sans-serif;mso-fareast-language:EN-US'>Zimbabwe COVID19 Update<o:p></o:p></span></h1><p class=MsoNormal style='background:white'><span style='font-size:11.5pt;font-family:"Segoe UI",sans-serif;color:#0F1419'>COVID-19 update: As at 18 February 2021, Zimbabwe had 35 543 confirmed cases, including 31 821 recoveries and 1 420 deaths.</span><span style='font-family:"Verdana",sans-serif;color:#1F497D'> <br><br></span><span style='font-family:"Verdana",sans-serif;color:#1F497D;mso-fareast-language:EN-ZW'><img border=0 width=672 height=884 id="Picture_x0020_2" src="cid:image005.jpg@01D706AD.04176570" alt=Image></span><span style='font-family:"Verdana",sans-serif;color:#1F497D'> </span><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Rectangle_x0020_1" o:spid="_x0000_s1026" type="#_x0000_t75" alt="Image" style='width:23.75pt;height:23.75pt;visibility:visible;mso-left-percent:-10001;mso-top-percent:-10001;mso-position-horizontal:absolute;mso-position-horizontal-relative:char;mso-position-vertical:absolute;mso-position-vertical-relative:line;mso-left-percent:-10001;mso-top-percent:-10001'>
<w:wrap type="none"/>
<w:anchorlock/>
</v:shape><![endif]--><![if !vml]><img width=32 height=32 src="cid:image006.png@01D706AD.04176570" alt=Image v:shapes="Rectangle_x0020_1"><![endif]><span style='font-family:"Verdana",sans-serif;color:#1F497D'><o:p></o:p></span></p><h1 style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:15.0pt;margin-left:0cm;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black;letter-spacing:-.3pt'><br></span><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black;letter-spacing:-.3pt'>Bad Weather Slows Shots; U.S. Vaccine to Double: Virus Update<br></span><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black;font-weight:normal'>The U.S. vaccine supply is poised to double in the coming weeks and months, according to an <a href="https://www.bloomberg.com/news/articles/2021-02-18/how-many-vaccine-doses-are-available-u-s-should-see-a-surge" target="_blank" title="A U.S. Vaccine Surge Is Coming, With Millions of Doses Promised"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>analysis by Bloomberg</span></a>, allowing a broad expansion of doses administered across the country.<o:p></o:p></span></h1><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Winter storms in the U.S. continue to slow the vaccination drive, including in New York City, Florida and Puerto Rico. Anthony Fauci, the nation’s top infectious disease doctor, said inoculations have come to a “grinding halt” in some places. Massachusetts said it might send National Guard troops to pick up its next vaccine shipments.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Brazil became the <a href="https://www.bloomberg.com/news/articles/2021-02-18/brazil-hits-10-million-covid-cases-with-new-strain-taking-hold" target="_blank" title="Brazil Hits 10 Million Covid Cases With New Strain Taking Hold"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>third</span></a> country in the world to breach 10 million coronavirus cases. France is committing to donate 5% of its secured vaccine supplies to <a href="https://www.bloomberg.com/news/articles/2021-02-18/france-to-donate-5-of-its-vaccine-doses-to-poorer-countries" target="_blank" title="France to Donate 5% of Its Vaccine Doses to Poorer Countries (1)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>poorer countries</span></a>. The U.S. will contribute as much as <a href="https://www.bloomberg.com/news/articles/2021-02-18/biden-to-pledge-4-billion-to-vaccine-program-for-poorer-nations" target="_blank" title="Biden to Pledge $4 Billion to Vaccine Program for Poorer Nations"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>$4 billion</span></a> to the global effort to fund vaccinations in lower-income countries, but doesn’t plan on shipping any of its own vaccines abroad until the nation’s own demand has been met.<br><br><o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=key-developments><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Biden to Pledge $4 Billion to Vaccines for Poorer Nations <br></span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The U.S. will contribute as much as <a href="https://www.bloomberg.com/news/articles/2021-02-18/biden-to-pledge-4-billion-to-vaccine-program-for-poorer-nations" target="_blank" title="Biden to Pledge $4 Billion to Vaccine Program for Poorer Nations"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>$4 billion</span></a> to Covax, the global effort to fund vaccinations in lower-income countries, but doesn’t plan on shipping any of its own vaccines abroad until the nation’s own demand has been met, officials familiar with the matter said.<o:p></o:p></span></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><o:p> </o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>President Joe Biden will announce during a Group of Seven call on Friday that the U.S. will commit $2 billion immediately to the program and pledge another $2 billion with conditions designed to spur contributions from other countries, said the officials, who spoke to reporters on condition of anonymity.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=illinois-cases-of-uk-strain-almost-double-438-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Illinois Cases of U.K. Strain Almost Double</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Illinois reported 17 more cases of the more-transmissible strain of the coronavirus first found in the U.K. That almost doubled the number of known cases to 42, state data <a href="http://dph.illinois.gov/covid19/variants" target="_blank" title="Illinois Department of Public Health website"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>show.</span></a> The state also has one case of the variant first found in South Africa.<br><br><o:p></o:p></span></h3><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Meantime, Alabama said it has eight cases of the variant. But the Department of Public Health <a href="https://twitter.com/ALPublicHealth/status/1362489040797388802" target="_blank" title="Alabama Department of Public Health Twitter"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>tweeted</span></a> that “only a couple of the cases had out-of-state travel prior to illness onset which indicates this variant strain is already circulating in Alabama.”<br><br><o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Nationwide, there almost 1,300 reported cases of the U.K. variant, called B.1.1.7, in 42 states, the U.S. Centers for Disease Control and Prevention <a href="https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html" target="_blank" title="CDC Variant webpage"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>says.</span></a> The body has projected that the strain, which U.K. scientists say is “likely” more lethal, may become dominant in the U.S. as early as March.<br><br><o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=florida-nears-30000-deaths-311-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Florida Nears 30,000 Deaths</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Florida is poised to pass 30,000 total fatalities, the fourth state in the U.S. to do so.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The state hit 29,990 deaths, combining residents and non-residents, on Thursday amid declining cases, hospitalizations and, more recently, fatalities. In order, the states with the most deaths are California, New York and Texas, each with more than 40,000.<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Earlier, Governor Ron DeSantis said the Moderna vaccine shipment that the state usually gets early in the week could now arrive as late as Monday as a result of winter weather across the nation. “Because of the storms that we’re seeing throughout the country, it’s basically sitting in the <span style='border:none windowtext 1.0pt;padding:0cm'>Fedex</span> warehouse,” DeSantis said Thursday in Pinellas Park.<br><br><o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=brazil-hits-10-million-covid-cases-308-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Brazil Hits 10 Million Covid Cases</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Brazil cases surpassed <a href="https://www.bloomberg.com/news/terminal/QOQRVADWX2PU" target="_blank" title="Brazil Tops 10m Covid Infections After 51,879 Cases in 24h (1)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>10 million,</span></a> with infections picking up speed in recent weeks as a new variant spreads amid a shortage of vaccines.<o:p></o:p></span></h3><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Latin America’s largest nation reported 51,879 new cases Thursday, pushing the total confirmed to 10,030,626, according to Health Ministry data. It’s a toll that lags only the U.S. and India. Deaths rose by 1,367 to 243,457, the second-highest globally.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“Brazil’s situation is really bad, with contagion at high levels. We’re seeing health systems in several states either in collapse or close to it,” said Estevao Urbano, an infectious disease expert and director at Brazil’s Infectology Society.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=mexico-warns-against-counterfeit-pfizer-vaccine-254-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Mexico Warns Against Counterfeit Pfizer Vaccine</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><br>Mexico issued a warning on the alleged <a href="https://www.bloomberg.com/news/terminal/QOQORJT0AFB6" target="_blank" title="Mexico Health Agency Warns Against Counterfeit Pfizer Vaccine"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>illegal application</span></a> of Pfizer’s vaccine in the state of Nuevo Leon, according to health agency Cofepris.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Th vaccine has not been authorized for sale to the private sector, so any substance acquired through an intermediary is false, it said.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=a-us-vaccine-surge-is-coming-248-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A U.S. Vaccine Surge Is Coming</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>The U.S. vaccine supply is poised to double in the coming weeks and months, according to an <a href="https://www.bloomberg.com/news/articles/2021-02-18/how-many-vaccine-doses-are-available-u-s-should-see-a-surge" target="_blank" title="A U.S. Vaccine Surge Is Coming, With Millions of Doses Promised"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>analysis by Bloomberg</span></a>, allowing a broad expansion of doses administered across the country.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Currently, the U.S. is administering 1.6 million doses a day, constrained by the recent supply of about 10 million to 15 million doses a week. But Covid-19 vaccine manufacturers and U.S. officials have accelerated their production timelines and signaled that the spigots are about to open, providing hundreds of millions of doses to match the growing capacity to immunize people at pharmacies and mass-vaccination sites.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A review of drugmakers’ public statements and their supply deals suggests that the number of vaccines delivered should rise to almost 20 million a week in March, more than 25 million a week in April and May, and over 30 million a week June. By summer, it would be enough to give 4.5 million shots a day.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=france-to-donate-5-of-vaccine-to-poorer-countries-159-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>France to Donate 5% of Vaccine to Poorer Countries </span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'><br>France is committing to donate 5% of its secured Covid-19 vaccine supplies to <a href="https://www.bloomberg.com/news/articles/2021-02-18/france-to-donate-5-of-its-vaccine-doses-to-poorer-countries" target="_blank" title="France to Donate 5% of Its Vaccine Doses to Poorer Countries (1)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>poorer countries</span></a> through the World Health Organization-backed Covax program.<o:p></o:p></span></h3><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>A multilateral approach via Covax -- a global alliance many developing nations are relying on for inoculations -- is the most efficient way to show solidarity, a French official who asked not to be named in line with protocol, said Thursday.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>France hopes the U.S. will make financial commitments regarding vaccines during a Group of Seven summit on Friday, the official added.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=massachusetts-governor-may-send-troops-to-get-vaccine-147-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Massachusetts Governor May Send Troops to Get Vaccine</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Massachusetts Governor Charlie Baker said he’s considering sending National Guard troops to pick up the state’s next vaccine shipments to avoid any delay from bad weather. He said the doses are warehoused in Tennessee and Kentucky.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“We got told last night that we might see a significant delay in our next shipments,” the Republican governor told the Greater Boston Chamber of Commerce, according to the Boston Herald. “We can’t afford to go what will be almost a week without getting any new doses from the feds, and continue to maintain the appointment schedules that people here expect and anticipate.”<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=israel-to-vaccinate-palestinian-workers-ynet-says-1255-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Israel to Vaccinate Palestinian Workers, Ynet Says</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Israel plans to begin <a href="https://www.bloomberg.com/news/terminal/QOQDWWT0G1L0" target="_blank" title="Israel to Vaccinate Palestinian Workers With Moderna, Ynet Says"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>vaccinating Palestinians</span></a> who work legally in its territory against Covid-19 using Moderna Inc. doses, news website Ynet reported Thursday.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The country’s inoculation drive is without parallel globally with more than 45% of the population receiving a first vaccine, but it has faced criticism for not offering jabs to millions of Palestinians who live under its control.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=canada-speeds-vaccines-after-slow-start-1237-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Canada Speeds Vaccines After Slow Start <br></span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Canada has begun to <a href="https://www.bloomberg.com/news/articles/2021-02-18/covid-19-shots-on-track-to-ramp-up-in-canada-despite-slow-start" target="_blank" title="Covid-19 Shots on Track to Ramp Up in Canada Despite Slow Start"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>accelerate</span></a> its vaccine rollout after delivery disruptions became a major political headache for Prime Minister Justin Trudeau.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>In an update by public-health officials Thursday, the government announced the pace of deliveries of both the Pfizer Inc.-BioNTech SE and Moderna Inc. shots is ramping up as of this week.<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>As many as 14.5 million of Canada’s 38 million people should be inoculated by the end of June, according to an updated timeline, up from the 13 million the government expected previously. Should vaccine candidates from AstraZeneca Plc, Johnson & Johnson and Novavax Inc. win regulatory approval, the tally could climb to 24.5 million.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=fauci-says-weather-slowing-vaccinations-1229-pm-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Fauci Says Weather Slowing Vaccinations</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Anthony Fauci, the top infectious disease doctor in the U.S., said winter storms and bad weather have brought vaccinations to a “grinding halt” in some places.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>He said he did not know the precise extent of the national slowdown but said on MSNBC it was “a problem.”<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“We’re just going to have to make up for it -- namely, do double time when this thing clears up,” he said. Vaccines have been administered below the daily average of 1.6 million shots, measured over a week, for the last three days, according to the <a href="https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/" target="_blank" title="More Than 186 Million Shots Given: Covid-19 Vaccine Tracker (Correct)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>Bloomberg vaccine tracker.</span></a><br><br><o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=nyc-loses-vaccine-supply-because-of-weather-1052-am-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>NYC Loses Vaccine Supply Because of Weather</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>New York City Mayor Bill de Blasio said snowstorms and bad weather resulted in the loss of several days of vaccine supply, as well as the delayed open of two vaccination sites. He said 30,000 to 35,000 appointments had to be held back and that initial deliveries of this week’s doses may not start until Saturday or Sunday.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Usually the city receives deliveries on Tuesdays or Wednesdays, de Blasio said. Officials said vaccine sites remain open today and that appointments for people getting their second shots won’t be impacted, but that in many cases it has had to stop scheduling new appointments. The city has administered 1.4 million vaccinations since it began its inoculation drive in December.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>To decrease the disparities among New Yorkers getting the vaccine, de Blasio said the city has sent out 250 canvassers to the hardest-hit communities and public housing sites to help people sign up.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=weather-delays-vaccines-in-puerto-rico-1042-am-ny><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Weather Delays Vaccines in Puerto Rico</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Puerto Rico said it was pushing all first-dose vaccinations scheduled for this week until March 3 or 4. Those receiving their second dose this week, however, will not see a change in their schedule.<o:p></o:p></span></h3><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Plunging temperatures and power outages in the southern and eastern U.S. have disrupted vaccine delivery, Health Secretary Carlos Mellado said in a statement. The U.S. territory of 3.2 million people has administered about 399,711 doses of both the Moderna and Pfizer-BioNTech vaccines.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>“Unfortunately, the weather is unpredictable,” he said. “We will continue to monitor the situation and concentrate on guaranteeing the second dose.”<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=south-africa-told-it-can-use-pfizer-shot-655-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>South Africa Told It Can Use Pfizer Shot <br></span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>South Africa <a href="https://www.bloomberg.com/news/terminal/QOPZ1EDWRGG1" target="_blank" title="S. Africa Can Proceed With Pfizer Shots After Study: Africa CDC"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>can press ahead</span></a> with the use of the the Pfizer/BioNTech Covid-19 vaccine in the wake of a study showing how it stimulates neutralizing antibodies against the locally dominant coronavirus variant, according to the Africa Centres for Disease Control and Prevention.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>In an online briefing, Africa CDC Director John Nkengasong said “what we are seeing based on the studies is not huge changes in neutralizing the antibodies of this virus.”<o:p></o:p></span></p><p style='margin:0cm;margin-bottom:.0001pt;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The lab-based study of the Pfizer/BioNTech shot <a href="https://www.bloomberg.com/news/articles/2021-02-17/pfizer-shot-produces-fewer-antibodies-versus-south-africa-strain" target="_blank" title="Pfizer Shot Elicits Fewer Antibodies Vs. South Africa Strain (1)"><span style='color:black;border:none windowtext 1.0pt;padding:0cm;text-decoration:none'>showed</span></a> it stimulated roughly two-thirds lower levels of neutralizing antibodies against the South African variant.<br><br><o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=vaccinemakers-to-begin-trials-with-pregnant-women-639-pm-hk><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Vaccine-Makers to Begin Trials With Pregnant Women</span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'> <br>Vaccine developers are set to begin trials for pregnant women, looking <span style='border:none windowtext 1.0pt;padding:0cm'>to provide reassurance</span> the shots are safe.<o:p></o:p></span></h3><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Pfizer and BioNTech are starting trials for their messenger RNA vaccine in 4,000 women in the latter stages of pregnancy, according to the U.S. online clinical trial registry. AstraZeneca Plc. and Johnson & Johnson are planning to run trials in the coming months.<o:p></o:p></span></p><p style='mso-margin-top-alt:22.5pt;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Until now, pregnant women have been excluded from vaccine studies even while they are more vulnerable to severe Covid-19. Some studies have also linked the disease to premature birth.<o:p></o:p></span></p><h3 style='mso-margin-top-alt:9.25pt;margin-right:0cm;margin-bottom:9.25pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit' id=uk-airlines-call-for-clarity-over-reopening-plans-619-pm><b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>U.K. Airlines Call for Clarity Over Reopening Plans <br></span></b><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>The U.K. airline industry <span style='border:none windowtext 1.0pt;padding:0cm'>stepped up</span> a campaign to persuade Prime Minister Boris Johnson that travel should be included in his plan to reopen the economy, calling for a clear road map to ease travel restrictions ahead of the crucial summer season.<o:p></o:p></span></h3><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:22.5pt;margin-left:0cm;background:white;vertical-align:baseline;font-variant:inherit;font-weight:inherit;font-stretch: inherit;line-height:inherit'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:black'>Heads of carriers including EasyJet Plc and Virgin Atlantic Airways Ltd. stressed the importance of the sector to the economy and employment. Overseas trips are effectively banned for most British people under lockdown rules, while incoming travelers are forced to take multiple Covid-19 tests and, in many cases, mandatory hotel quarantines.<o:p></o:p></span></p><p style='mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:20.25pt;margin-left:0cm;background:white'><span style='font-size:11.0pt;font-family:"Verdana",sans-serif;color:#1F497D'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:10.05pt'><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:10.05pt'><p class=MsoNormal style='text-indent:33.35pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:auto;margin-left:36.0pt;line-height:115%;background:white'><b><span style='font-family:"Verdana",sans-serif;mso-fareast-language:EN-ZW'><o:p> </o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:10.05pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr><td width=914 colspan=4 style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><strong><span lang=EN-US style='font-family:"Verdana",sans-serif'>INVESTORS DIARY 2021</span></strong><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=217 style='width:163.0pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='text-indent:12.6pt;line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Company</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=201 style='width:150.95pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Event</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Venue</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><b><span lang=EN-US style='font-family:"Verdana",sans-serif'>Date & Time</span></b><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=217 valign=top style='width:163.0pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=201 style='width:150.95pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=191 valign=top style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='margin-left:72.0pt;text-indent:-72.0pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=217 valign=top style='width:163.0pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=201 style='width:150.95pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=191 valign=top style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='margin-left:72.0pt;text-indent:-72.0pt;line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=419 colspan=2 valign=top style='width:313.95pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Companies under Cautionary<o:p></o:p></span></b></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></b></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#D9D9D9;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><b><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></b></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=419 colspan=2 valign=top style='width:313.95pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=419 colspan=2 valign=top style='width:313.95pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>ART<o:p></o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>PPC<o:p></o:p></span></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Dairibord<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr style='height:3.25pt'><td width=419 colspan=2 valign=top style='width:313.95pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Starafrica<o:p></o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Fidelity<o:p></o:p></span></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Turnall<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr style='height:3.25pt'><td width=419 colspan=2 valign=top style='width:313.95pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Medtech<o:p></o:p></span></p></td><td width=304 style='width:228.2pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Zimre<o:p></o:p></span></p></td><td width=191 valign=bottom style='width:143.0pt;border:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;height:3.25pt'><p class=MsoBodyText style='margin:0cm;margin-bottom:.0001pt;line-height:105%'><span lang=EN-US style='font-size:11.0pt;line-height:105%;font-family:"Verdana",sans-serif'>Nampak Zimbabwe<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm;height:3.25pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#1F497D;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#1F497D;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-US style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif;color:white'>DISCLAIMER: This report has been prepared by Bulls ‘n Bears, a division of Faith Capital (Pvt) Ltd for general information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities. The information contained in this report has been compiled from sources believed to be reliable, but no representation or warranty is made or guarantee given as to its accuracy or completeness. All opinions expressed and recommendations made are subject to change without notice. Securities or financial instruments mentioned herein may not be suitable for all investors. Securities of emerging and mid-size growth companies typically involve a higher degree of risk and more volatility than the securities of more established companies. Neither Faith Capital nor any other member of Bulls ‘n Bears nor any other person, accepts any liability whatsoever for any loss howsoever arising from any use of this report or its contents or otherwise arising in connection therewith. Recipients of this report shall be solely responsible for making their own independent investigation into the business, financial condition and future prospects of any companies referred to in this report. Other Indices quoted herein are for guideline purposes only and sourced from third parties.</span></i><i><span lang=EN-US style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p></o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><i><span lang=EN-GB style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif'><o:p> </o:p></span></i></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=top style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-size:8.0pt;line-height:105%;font-family:"Verdana",sans-serif'>(c) 2021 <b>Web</b>:<a href="http://www.bullszimbabwe.com"><span style='color:windowtext;text-decoration:none'> www.bullszimbabwe.com </span></a><b>Email:</b> <a href="mailto:info@bulls.co.zw"><span style='color:windowtext;text-decoration:none'>info@bulls.co.zw</span></a> <b>Tel:</b> +263 4 2927658 <b>Cell:</b> +263 77 344 1674<o:p></o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr><tr><td width=914 colspan=4 valign=bottom style='width:685.15pt;border-top:none;border-left:solid white 1.0pt;border-bottom:none;border-right:solid white 1.0pt;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></td><td width=6 style='width:4.4pt;padding:0cm 0cm 0cm 0cm'><p class=MsoNormal style='line-height:105%'><span lang=EN-US style='font-family:"Verdana",sans-serif'> <o:p></o:p></span></p></td></tr></table></div><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Verdana",sans-serif'><o:p> </o:p></span></p></div></body></html>